G298-0246 Screening compound: 3-[7-(3-fluorophenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-[2-(4-sulfamoylphenyl)ethyl]propanamide

G298-0246 Screening compound: 3-[7-(3-fluorophenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-[2-(4-sulfamoylphenyl)ethyl]propanamide
G298-0246 Screening compound: 3-[7-(3-fluorophenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-[2-(4-sulfamoylphenyl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G298-0246
3-[7-(3-fluorophenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-[2-(4-sulfamoylphenyl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G298-0246

Molecular Formula

C22H21FN6O4S (C22 H21 FN6 O4 S)

Compound Name

3-[7-(3-fluorophenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]-N-[2-(4-sulfamoylphenyl)ethyl]propanamide

IUPAC name

3-[7-(3-fluorophenyl)-8-oxo-7H8H-[124]triazolo[43-a]pyrazin-3-yl]-N-[2-(4-sulfamoylphenyl)ethyl]propanamide

SMILES

NS(c1ccc(CCNC(CCc2nnc3n2C=CN(c2cc(F)ccc2)C3=O)=O)cc1)(=O)=O

InChI

InChI=1S/C22H21FN6O4S/c23-16-2-1-3-17(14-16)28-12-13-29-19(26-27-21(29)22(28)31)8-9-20(30)25-11-10-15-4-6-18(7-5-15)34(24,32)33/h1-7,12-14H,8-11H2,(H,25,30)(H2,24,32,33)

InChI Key

DQTIYTHLZGBAAC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14995807

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

484.51

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

-1.034

Distribution Coefficient, logD

-1.034

Water Solubility, LogSw

-2.03

Polar Surface Area

114.013

Acid Dissociation Constant (pKa)

10.18

Base Dissociation Constant (pKb)

0.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

G298-0246 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • Epigenetic
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with G298-0246 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G298-0246?
Check Price and Availability of G298-0246, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G298-0246 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G298-0246
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G298-0246
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G298-0246 available by request